Cargando…
Rosuvastatin Reduces Neuroinflammation in the Hemorrhagic Transformation After rt-PA Treatment in a Mouse Model of Experimental Stroke
Hemorrhagic transformation (HT) is a serious complication that stimulates inflammation during reperfusion therapy after acute ischemic stroke. Rosuvastatin, a 3-hydroxymethyl-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, might improve the outcome of HT by inhibiting neuroinflammation. T...
Autores principales: | Lu, Dan, Liu, Yanfang, Mai, Hongcheng, Zang, Jiankun, Shen, Lingling, Zhang, Yusheng, Xu, Anding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082938/ https://www.ncbi.nlm.nih.gov/pubmed/30116175 http://dx.doi.org/10.3389/fncel.2018.00225 |
Ejemplares similares
-
HMG-CoA Reductase Inhibitors Attenuate Neuronal Damage by Suppressing Oxygen Glucose Deprivation-Induced Activated Microglial Cells
por: Lu, Dan, et al.
Publicado: (2019) -
Efficacy of Rosuvastatin Combined with rt-PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients
por: Zhu, Jianzhong, et al.
Publicado: (2022) -
Warfarin Anticoagulation Exacerbates the Risk of Hemorrhagic Transformation after rt-PA Treatment in Experimental Stroke: Therapeutic Potential of PCC
por: Pfeilschifter, Waltraud, et al.
Publicado: (2011) -
Identification of Blood Circular RNAs as Potential Biomarkers for Acute Ischemic Stroke
por: Lu, Dan, et al.
Publicado: (2020) -
Retracted: Efficacy of Rosuvastatin Combined with rt-PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)